Literature DB >> 6776179

Effects of chronic heroin addiction on pituitary-thyroid function in man.

F Brambilla1, P Nobile, A Zanoboni, W Zanoboni-Muciaccia, P L Meroni.   

Abstract

Pituitary-thyroid function has been studied in heroin addicts. Data have been obtained in 10 male addicts, aged 18-24 years, with histories of addiction to heroin alone lasting from 8 months to 4 years, and in 9 controls matched for sex and age. Basal plasma levels of TSH, T4 and T3 were measured. A TRH stimulation test was done, injecting 500 micrograms of TRH iv as a bolus and assaying TSH levels before the injection and at 30 min intervals up to 2 h afterwards. The results revealed no difference between addicts and controls in basal levels of TSH, T4 and T3. The TRH stimulation test induced a blunted TSH rise in 50% of the cases. The possible mechanism of action of heroin on pituitary-thyroid axis is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776179     DOI: 10.1007/BF03348271

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  31 in total

1.  Changes in the striatal adenylate cyclase activity following acute and chronic morphine treatment and during withdrawal.

Authors:  S K Puri; L Volicer; J Cochin
Journal:  J Neurochem       Date:  1976-12       Impact factor: 5.372

2.  Blocking of the thyrotrophic hormone secretion by morphine and chlorpromazine in rats.

Authors:  M SAMEL
Journal:  Arch Int Pharmacodyn Ther       Date:  1958-10-01

3.  Glucose-insulin metabolism in herion addicts.

Authors:  F Brambilla; A Guerrini; A Guastalla; P Beretta; D D Maio
Journal:  Neuropsychobiology       Date:  1976       Impact factor: 2.328

4.  Late effects of perinatal morphine administration on pituitary-thyroidal and gonadal function.

Authors:  J L Bakke; N L Lawrence; J Bennett
Journal:  Biol Neonate       Date:  1973

5.  Hypothalamic-pituitary-adrenal axis in methadone-treated heroin addicts.

Authors:  P Cushman; B Bordier; J G Hilton
Journal:  J Clin Endocrinol Metab       Date:  1970-01       Impact factor: 5.958

6.  Thyroid activity following intracerebral injection of morphine in the rat.

Authors:  P Lomax; N Kokka; R George
Journal:  Neuroendocrinology       Date:  1970       Impact factor: 4.914

7.  Increased serum thyroxine levels in euthyroid narcotic addicts.

Authors:  J B Webster; J J Coupal; P Cushman
Journal:  J Clin Endocrinol Metab       Date:  1973-12       Impact factor: 5.958

8.  Deranged anterior pituitary responsiveness to hypothalamic hormones in depressed patients.

Authors:  F Brambilla; E Smeraldi; E Sacchetti; F Negri; D Cocchi; E E Müller
Journal:  Arch Gen Psychiatry       Date:  1978-10

9.  Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man.

Authors:  G Tolis; J Hickey; H Guyda
Journal:  J Clin Endocrinol Metab       Date:  1975-10       Impact factor: 5.958

10.  Fasting blunts the TSH response to synthetic thyrotropin-releasing hormone (TRH).

Authors:  A I Vinik; W J Kalk; H McLaren; S Hendricks; B L Pimstone
Journal:  J Clin Endocrinol Metab       Date:  1975-03       Impact factor: 5.958

View more
  3 in total

1.  Prevalence and correlates of sexual risk behaviors among drug users in western China: implications for HIV transmission.

Authors:  Jiegang Huang; Junjun Jiang; Jonathan Z Li; Xiaobo Yang; Wei Deng; Abu S Abdullah; Bo Qin; Halmurat Upur; Chaohui Zhong; Qianqiu Wang; Qian Wang; Yuhua Ruan; Yunfeng Zou; Li Ye; Peiyan Xie; Fumei Wei; Na Xu; Bo Wei; Hao Liang
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-13       Impact factor: 2.205

2.  The effect of opium addiction on thyroid function tests.

Authors:  Mohammad Hossein Gozashti; Elham Mohammadzadeh; Kouros Divsalar; Mostafa Shokoohi
Journal:  J Diabetes Metab Disord       Date:  2014-01-06

3.  Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts.

Authors:  Bing-Ying Zhou; Shi-Yan Yan; Wan-Lu Shi; Zhi Qu; Xin Zhao; Zhi-Min Liu; Xiao-Ping Pu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.